Yes, Tdap and IPV can be administered together
Tdap and IPV vaccines can be safely given simultaneously at the same visit, administered at different anatomic sites using separate syringes. This is explicitly supported by ACIP guidelines and is standard practice.
Key Guidance
Simultaneous Administration is Permitted
ACIP clearly states that inactivated vaccines (including both Tdap and IPV) can be administered simultaneously at different anatomic sites or at any time interval between doses 1. There is no required waiting period between these vaccines when given separately.
Combination Vaccines Available
Several FDA-licensed combination vaccines already contain both components:
- DTaP-IPV (Kinrix): Licensed for children aged 4-6 years as the fifth DTaP dose and fourth IPV dose 2
- DTaP-IPV/Hib (Pentacel): Licensed for children 6 weeks through 4 years 1
- DTaP-IPV-Hib-HepB: Licensed for infants at 2,4, and 6 months 3
The existence of these licensed combination products demonstrates that the antigens are compatible and can be given together safely.
Clinical Evidence
Multiple studies confirm the safety and immunogenicity of combined administration:
- Clinical trials showed that combined DTaP-IPV and separately administered DTaP and IPV vaccines had comparable safety and reactogenicity profiles 2
- Immunogenicity of all antigens was similar between combined and separate administration 2, 4
- Studies in adolescents and adults demonstrated that TdaP-IPV combinations are safe and immunogenic 5
Practical Administration
When giving Tdap and IPV together:
- Use separate syringes if giving as individual vaccines
- Administer at different anatomic sites (e.g., one in each deltoid, or deltoid and anterolateral thigh in young children)
- The preferred site for both vaccines in persons ≥3 years is the deltoid muscle 6
- Both are given as 0.5 mL intramuscular injections
Important Considerations
No Interval Required
Unlike live vaccines, which may require specific spacing, no minimum interval is necessary between Tdap and IPV whether given simultaneously or sequentially 7, 8. This applies to both simultaneous and nonsimultaneous vaccination.
Age-Specific Formulations
- Tdap is for persons ≥7 years of age 6
- DTaP-IPV combinations are for children <7 years 2, 3
- Ensure age-appropriate formulations are used
Common Pitfall to Avoid
Do not confuse the need for spacing between diphtheria toxoid-containing vaccines (where shorter intervals may increase local reactions) with the ability to give Tdap and IPV together. While ACIP notes that persons receiving diphtheria toxoid-containing vaccines in close succession may have increased adverse reactions 7, this refers to giving multiple doses of the same vaccine type (e.g., Tdap followed by another Tdap), not to giving Tdap and IPV simultaneously at a single visit.